The World Health Organization (WHO) has declared that "antimicrobial resistance (AMR) is one of the top 10 global health threats facing humanity.”¹

PRESERVE OUR ANTIMICROBIALS

WHO urges that we all take immediate steps towards judicious use of antimicrobials.¹ We agree.

In line with WHO principles, Pfizer’s PRESERVE strategy supports innovation and encourages sustainable, responsible use of and access to antimicrobials. We live these stewardship practices every day, so we can accelerate real change against resistance.

Our approach is based on 8 core pillars, each with its own targets and objectives.

DIAGNOSTIC UNITY ACROSS THE COMMUNITY

For advocates of antimicrobial stewardship, diagnostic tools are critical.^2,3
 

Diagnostic testing is essential to ensure patients receive the appropriate therapy earlier.

Using diagnostic tools reduces pathogen transmission, as people are infected for shorter

lengths of time, and supports good antimicrobial stewardship.^2,3
 

Antimicrobial susceptibility testing can determine if an infection is likely to respond to a

particular antimicrobial therapy, and can lead to a more targeted treatment.^3,4
 

Ordering the right tests for the right patient at the right time requires effective communication

and multidisciplinary collaboration.⁵ We must share diagnostic knowledge and expertise to get

closer to our goal: curb the threat of drug-resistant infections.